The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 7, 2011, Pages 969-974

  Lim, Ji Won ^a   Kim, Min Uk ^a  

^a Hallym University   (South Korea)

Author keywords

Angiography; Central serous chorioretinopathy; Intravitreal bevacizumab injection

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE STUDY; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA LUTEA; SUBRETINAL FLUID; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CENTRAL SEROUS CHORIORETINOPATHY; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 79959752215     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-010-1581-9     Document Type: Article

References (21)

1. Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 96:854-859 (Pubitemid 19165113)
2. Hussain D, Gass JD (1998) Idiopathic central serous chorioretinopathy. Indian J Ophthalmol 46:131-137 (Pubitemid 128519388)
3. Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE (2002) Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina 22:19-24 (Pubitemid 41070746)
4. Robertson DM, Ilstrup D (1983) Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 95:457-466 (Pubitemid 13128571)
5. Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073-1080 (Pubitemid 38759356)
6. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756-1765
7. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235-237 (Pubitemid 36548818)
8. Torres-Soriano ME, Garcia-Aguirre G, Kon-Jara V, Ustariz-Gonzáles O, Abraham-Marín M, Ober MD, Quiroz-Mercado H (2008) A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 246:1235-1239
9. Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S (2009) Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 19:613-617
10. Seong HK, Bae JH, Kim ES, Han JR, Nam WH, Kim HK (2009) Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect. Ophthalmologica 223:343-347
11. Lim SJ, Roh MI, Kwon OW (2010) Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 30:100-106
12. Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H (2010) Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study. Curr Eye Res 35:91-98
13. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057-1062 (Pubitemid 24272611)
14. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203-213
15. Prünte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 9:37-41
16. Piccolino FC, Borgia L, Zinicola E, Zingirian M (1995) Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 9:324-332
17. Iida T, Kishi S, Hagimura N, Shimizu K (1999) Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508-551
18. Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU (2007) Tübingen bevacizumab study group, Schraermeyer U: Ultrastructural findings in primate eye after intravitreal injection of bevacimuzab. Am J Ophthalmol 143:995-1002
19. Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U, Bartz-Schmidt KU (2007) Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br J Ophthalmol 91:827-831 (Pubitemid 46846661)
20. Lim JW, Kim MU, Shin MC (2010) Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy. Retina 30:1465-1471
21. Inoue R, Sawa M, Tsujikawa M, Gomi F (2010) Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 149:441-446